Impact of CD34+stem cell dose on early mortality after allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Neumann, K. [1 ]
Lange, S. [1 ]
Kragl, B. [1 ]
Glass, A. [2 ]
Grosse-Thie, C. [1 ]
Wittke, C. [1 ]
Freitag, S. [1 ]
Henze, L. [1 ]
Kleine, H. -D. [3 ]
Junghanss, C. [1 ]
机构：
[1] Univ Rostock, Hematol Oncol Palliat Care, D-18055 Rostock, Germany
[2] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany
[3] Seracell Stammzelltechnol GmbH, Rostock, Germany
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
AB10
引用
收藏
页码：S567 / S567
页数：1
相关论文
共 50 条
  • [1] High CD34+cell dose is associated with increased early mortality after allogeneic hematopoietic stem cell transplantation
    Neumann, K.
    Lange, S.
    Kragl, B.
    Glass, Ae
    Grosse-Thie, C.
    Wittke, C.
    Freitag, S.
    Henze, L.
    Kleine, H. -D
    Junghanss, C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 80 - 80
  • [2] Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
    Remberger, Mats
    Torlen, Johan
    Ringden, E.
    Engstrom, Mats
    Watz, Emma
    Uhlin, Michael
    Mattsson, Jonas
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (05) : 889 - 893
  • [3] Impact of infused CD34+stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide
    Hany, Elmariah
    Naqvi, Syeda Mahrukh Hussnain
    Kim, Jongphil
    Nishihori, Taiga
    Mishra, Asmita
    Perez, Lia
    Faramand, Rawan
    Lazaryan, Aleksandr
    Liu, Hien D.
    Khimani, Farhad
    Nieder, Michael
    Anasetti, Claudio
    Pidala, Joseph
    Bejanyan, Nelli
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1683 - 1690
  • [4] The Effect of Age and CD34+Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma - Single Institution Experience
    Skousen, Madeline
    Holstein, Sarah A.
    Lunning, Matthew A.
    Lyden, Elizabeth R.
    Sheree, Gilmore
    Schmit-Pokorny, Kimberly
    Armitage, James O.
    Al-Kadhimi, Zaid S.
    Vose, Julie M.
    Baljevic, Muhamed
    [J]. BLOOD, 2019, 134
  • [5] Optimizing the CD34+cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation
    Mehta, Jayesh
    Frankfurt, Olga
    Altman, Jessica
    Evens, Andrew
    Tallman, Martin
    Gordon, Leo
    Williams, Stephanie
    Winter, Jane
    Krishnamurthy, Jairam
    Duffey, Sara
    Singh, Veerpal
    Meagher, Richard
    Grinblatt, David
    Kaminer, Lynne
    Singhal, Seema
    [J]. LEUKEMIA & LYMPHOMA, 2009, 50 (09) : 1434 - 1441
  • [6] HEMATOPOIETIC RECOVERY AFTER STEM-CELL TRANSPLANTATION - IMPACT OF CD34+ CELL DOSE AND METHOD OF MOBILIZATION
    BORSON, R
    BROWN, R
    HENDRICKS, D
    EHLENBECK, C
    DIPERSIO, JF
    [J]. BLOOD, 1994, 84 (10) : A349 - A349
  • [7] The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation
    Ilhan, O
    Arslan, Ö
    Arat, M
    Beksaç, M
    Akan, H
    Özcan, M
    Gürman, G
    Konuk, N
    Uysal, A
    Koç, H
    [J]. TRANSFUSION SCIENCE, 1999, 20 (01): : 69 - 71
  • [8] CD34+-selected stem cell "Boost" for poor graft function after allogeneic hematopoietic stem cell transplantation
    Mohty, R.
    Brissot, E.
    Battipaglia, G.
    Ruggeri, A.
    Sestili, S.
    Mediavilla, C.
    Belhocine, R.
    Dulery, R.
    Mohty, M.
    Malard, F.
    [J]. CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2019, 67 (03) : 112 - 114
  • [9] Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation
    Yamamoto, Chihiro
    Ogawa, Hiroyasu
    Fukuda, Takahiro
    Igarashi, Aiko
    Okumura, Hirokazu
    Uchida, Naoyuki
    Hidaka, Michihiro
    Nakamae, Hirohisa
    Matsuoka, Ken-Ichi
    Eto, Tetsuya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kanda, Yoshinobu
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 708 - 716
  • [10] Absence of CD34-hematopoietic precursor population in the recipients of CD34+stem cell transplantation.
    Ando, K
    Kato, S
    Yabe, H
    Yabe, M
    Nakamura, Y
    Hotta, T
    [J]. BLOOD, 2000, 96 (11) : 113B - 113B
12345